Enfermedades Neurológicas

Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies

The Lancet Neurology Volume 16, No. 5, p351–359, May 2017 Dr Daryl J Wile, Pankaj A Agarwal, DM, Prof Michael...

Decrease in Aβ42 predicts dopa-resistant gait progression in early Parkinson disease

Neurology Journal April 18, 2017 vol. 88 no. 16 1501-1511 Lynn Rochester, PhD, Brook Galna, PhD, Sue Lord, PhD, Alison J. Yarnall, MRCP, Rosie Morris, MSc, Gordon Duncan,...

Cerebral glucose metabolism and cognition in newly diagnosed Parkinson’s disease: ICICLE-PD study

Journal of Neurology, Neurosurgery & Psychiatry Volume 88, Issue 4 M J Firbank, A J Yarnall, R A Lawson, G W...

Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults...

The Lancet Neurology Volume 16, No. 5, p377–389, May 2017 Prof Sandrine Andrieu, Sophie Guyonnet, PhD, Nicola Coley, PhD, Christelle...

Epileptic activity in Alzheimer’s disease: causes and clinical relevance

The Lancet Neurology Volume 16, No. 4, p311–322, April 2017 Dr Keith A Vossel, MD, Maria C Tartaglia, MD, Haakon B Nygaard,...